• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因扩增以及还原型叶酸载体在转运能力增强的K562细胞中的表达增加。

Gene amplification and increased expression of the reduced folate carrier in transport elevated K562 cells.

作者信息

Wong S C, Zhang L, Proefke S A, Hukku B, Matherly L H

机构信息

Experimental and Clinical Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA.

出版信息

Biochem Pharmacol. 1998 Apr 1;55(7):1135-8. doi: 10.1016/s0006-2952(97)00639-4.

DOI:10.1016/s0006-2952(97)00639-4
PMID:9605439
Abstract

The molecular bases for the 6-fold elevated methotrexate transport capacity of K562.4CF cells (Matherly et al., Cancer Res. 51: 3420-3426, 1991) were studied with reduced folate carrier (RFC) cDNA, genomic, and antibody probes. Southern analysis showed that RFC gene copies were increased (approximately 4- to 5-fold) in K562.4CF over wild-type K562 cells. Fluorescence in situ hybridization using a genomic RFC probe confirmed the localization of the RFC gene to the q-arm of chromosome 21. In K562.4CF cells, the frequent loss of a normal copy of chromosome 21 (61% of metaphases) was accompanied by RFC gene amplification and translocations of amplified RFC gene fragments to several (2 to 6) different chromosomal loci not seen in wild-type cells. Particularly intense RFC signals were mapped to homogeneously staining regions in chromosomes 2 and 15. Increased RFC gene copies were accompanied by a similar increase in the major 3.1 kb RFC transcript by northern blotting and an approximately 7-fold elevated level of the broadly migrating (80-95 kDa) RFC protein on a western blot probed with an RFC C-terminal peptide antibody. These results demonstrate that selection of cells with a growth-limiting concentration of reduced folates (0.4 nM of leucovorin) is sufficient to promote chromosomal aberrations, including gene amplification and translocations that result in increased RFC expression and folate transport.

摘要

利用还原型叶酸载体(RFC)的互补DNA、基因组及抗体探针,对K562.4CF细胞(Matherly等人,《癌症研究》51: 3420 - 3426, 1991)中氨甲蝶呤转运能力提高6倍的分子基础进行了研究。Southern分析显示,与野生型K562细胞相比,K562.4CF细胞中的RFC基因拷贝数增加(约4至5倍)。使用基因组RFC探针进行的荧光原位杂交证实,RFC基因定位于21号染色体的长臂。在K562.4CF细胞中,21号染色体正常拷贝的频繁丢失(61%的中期细胞)伴随着RFC基因扩增以及扩增的RFC基因片段易位至几个(2至6个)野生型细胞中未见的不同染色体位点。特别强烈的RFC信号定位于染色体2和15的均匀染色区。通过Northern印迹法检测到,RFC基因拷贝数增加伴随着主要的3.1 kb RFC转录本有类似增加,在用RFC C末端肽抗体进行Western印迹检测时,广泛迁移的(80 - 95 kDa)RFC蛋白水平升高了约7倍。这些结果表明,用生长限制浓度的还原型叶酸(0.4 nM亚叶酸钙)选择细胞足以促进染色体畸变,包括导致RFC表达和叶酸转运增加的基因扩增和易位。

相似文献

1
Gene amplification and increased expression of the reduced folate carrier in transport elevated K562 cells.基因扩增以及还原型叶酸载体在转运能力增强的K562细胞中的表达增加。
Biochem Pharmacol. 1998 Apr 1;55(7):1135-8. doi: 10.1016/s0006-2952(97)00639-4.
2
Chromosomal localization of the murine RFC-1 gene encoding a folate transporter and its amplification in an antifolate resistant variant overproducing the transporter.编码一种叶酸转运蛋白的小鼠RFC-1基因的染色体定位及其在过量产生该转运蛋白的抗叶酸抗性变体中的扩增。
Cancer Genet Cytogenet. 1998 Aug;105(1):29-38. doi: 10.1016/s0165-4608(98)00005-3.
3
Association of deletions and translocation of the reduced folate carrier gene with profound loss of gene expression in methotrexate-resistant K562 human erythroleukemia cells.还原型叶酸载体基因的缺失和易位与甲氨蝶呤耐药的K562人红白血病细胞中基因表达的显著丧失之间的关联。
Biochem Pharmacol. 2001 Mar 15;61(6):665-75. doi: 10.1016/s0006-2952(01)00535-4.
4
Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells.编码人还原型叶酸载体(RFC1)的基因的分离及其在转运缺陷型、甲氨蝶呤耐药人乳腺癌细胞中的表达分析。
Cancer Res. 1995 Sep 1;55(17):3790-4.
5
Effects of the loss of capacity for N-glycosylation on the transport activity and cellular localization of the human reduced folate carrier.
Biochim Biophys Acta. 1998 Oct 15;1375(1-2):6-12. doi: 10.1016/s0005-2736(98)00118-7.
6
Transcript heterogeneity of the human reduced folate carrier results from the use of multiple promoters and variable splicing of alternative upstream exons.人类还原型叶酸载体的转录本异质性源于多个启动子的使用以及可变上游外显子的可变剪接。
Biochem J. 1998 Jun 15;332 ( Pt 3)(Pt 3):773-80. doi: 10.1042/bj3320773.
7
Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy.儿童急性淋巴细胞白血病中叶酸盐载体基因表达降低:与免疫表型和倍性的关系
Clin Cancer Res. 1998 Sep;4(9):2169-77.
8
Impaired membrane transport in methotrexate-resistant CCRF-CEM cells involves early translation termination and increased turnover of a mutant reduced folate carrier.甲氨蝶呤耐药的CCRF-CEM细胞中膜转运受损涉及早期翻译终止和突变型还原型叶酸载体的周转增加。
J Biol Chem. 1999 Apr 9;274(15):10388-94. doi: 10.1074/jbc.274.15.10388.
9
Characterization of a human alternatively spliced truncated reduced folate carrier increasing folate accumulation in parental leukemia cells.一种人可变剪接截短型还原型叶酸载体的特性分析,该载体可增加亲代白血病细胞中的叶酸积累。
Eur J Biochem. 2000 Feb;267(3):690-702. doi: 10.1046/j.1432-1327.2000.01049.x.
10
Restoration of transport activity by co-expression of human reduced folate carrier half-molecules in transport-impaired K562 cells: localization of a substrate binding domain to transmembrane domains 7-12.通过在转运功能受损的K562细胞中共表达人还原型叶酸载体半分子来恢复转运活性:底物结合结构域定位于跨膜结构域7-12。
J Biol Chem. 2004 Nov 5;279(45):46755-63. doi: 10.1074/jbc.M408696200. Epub 2004 Aug 26.

引用本文的文献

1
Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate.RFC1、DHFR和MTHFR基因变异对接受大剂量甲氨蝶呤治疗的骨肉瘤患者的影响。
Pharmacogenomics J. 2015 Oct;15(5):385-90. doi: 10.1038/tpj.2015.11. Epub 2015 Mar 17.
2
Effects of a microRNA binding site polymorphism in SLC19A1 on methotrexate concentrations in Chinese children with acute lymphoblastic leukemia.SLC19A1基因中一个微小RNA结合位点多态性对中国急性淋巴细胞白血病儿童甲氨蝶呤浓度的影响
Med Oncol. 2014 Jul;31(7):62. doi: 10.1007/s12032-014-0062-0. Epub 2014 Jun 14.
3
Functional loss of the reduced folate carrier enhances the antitumor activities of novel antifolates with selective uptake by the proton-coupled folate transporter.
还原叶酸载体功能丧失增强了新型抗叶酸药物的抗肿瘤活性,这些药物通过质子偶联叶酸转运体选择性摄取。
Mol Pharmacol. 2012 Oct;82(4):591-600. doi: 10.1124/mol.112.079004. Epub 2012 Jun 26.
4
SLC19A1 pharmacogenomics summary.SLC19A1药物基因组学概述。
Pharmacogenet Genomics. 2010 Nov;20(11):708-15. doi: 10.1097/FPC.0b013e32833eca92.
5
Expression of resistance markers to methotrexate predicts clinical improvement in patients with rheumatoid arthritis.甲氨蝶呤耐药标志物的表达可预测类风湿关节炎患者的临床改善情况。
Ann Rheum Dis. 2005 Apr;64(4):564-8. doi: 10.1136/ard.2003.014985. Epub 2004 Sep 2.
6
The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter.人类还原型叶酸载体基因在正常人体组织中广泛且差异表达:七个非编码外显子的鉴定及一个新型启动子的表征
Biochem J. 2002 Nov 1;367(Pt 3):629-40. doi: 10.1042/BJ20020512.
7
Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia.亚甲基四氢叶酸还原酶(MTHFR)基因多态性与儿童急性白血病分子定义亚型的风险
Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4004-9. doi: 10.1073/pnas.061408298. Epub 2001 Mar 13.